Initial Experience of Sorafenib Neoadjuvant Therapy Combined with Retroperitoneoscopy in Treating T2 Large Renal Carcinoma

Figure 3

Histopathologic staining of RCC from the same patient before (a and b) and after (c and d) sorafenib treatment, where tumor hemorrhage, necrosis, and cystic degeneration were visible. (a) and (c) were at ×100 magnification. (b) and (d) were at ×400 magnification.

(a)

(b)

(c)

(d)